Helen Kotanides

1.5k total citations
16 papers, 1.2k citations indexed

About

Helen Kotanides is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Helen Kotanides has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Helen Kotanides's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Helen Kotanides is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Helen Kotanides collaborates with scholars based in United States, Canada and Germany. Helen Kotanides's co-authors include Nancy C. Reich, Larry Witte, Peter Böhlen, Daniel J. Hicklin, Patricia Rockwell, Bronislaw Pytowski, Zhenping Zhu, François Houle, Johannes Waltenberger and Jacques Landry and has published in prestigious journals such as Science, Journal of Biological Chemistry and Blood.

In The Last Decade

Helen Kotanides

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Kotanides United States 12 757 486 322 260 117 16 1.2k
Michelle B. Crosby United States 10 777 1.0× 516 1.1× 302 0.9× 171 0.7× 113 1.0× 12 1.4k
Laura Gualandi Sweden 9 966 1.3× 326 0.7× 136 0.4× 245 0.9× 97 0.8× 14 1.3k
Susana Constantino Rosa Santos Portugal 17 664 0.9× 464 1.0× 224 0.7× 250 1.0× 127 1.1× 41 1.3k
Cheryl J. Aslakson United States 6 553 0.7× 539 1.1× 371 1.2× 220 0.8× 73 0.6× 8 1.2k
Sina Koch Germany 15 1.3k 1.7× 417 0.9× 193 0.6× 288 1.1× 62 0.5× 22 2.0k
Rosana Meyer United States 23 1.1k 1.4× 308 0.6× 187 0.6× 220 0.8× 53 0.5× 37 1.4k
Jae Youn Yi South Korea 20 847 1.1× 453 0.9× 162 0.5× 172 0.7× 90 0.8× 37 1.3k
Andreas Menrad Germany 20 682 0.9× 513 1.1× 267 0.8× 206 0.8× 280 2.4× 30 1.5k
Lucia Fallavollita Canada 17 669 0.9× 685 1.4× 292 0.9× 421 1.6× 67 0.6× 23 1.5k
Hany Kayed Germany 23 923 1.2× 640 1.3× 141 0.4× 263 1.0× 90 0.8× 45 1.5k

Countries citing papers authored by Helen Kotanides

Since Specialization
Citations

This map shows the geographic impact of Helen Kotanides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Kotanides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Kotanides more than expected).

Fields of papers citing papers by Helen Kotanides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Kotanides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Kotanides. The network helps show where Helen Kotanides may publish in the future.

Co-authorship network of co-authors of Helen Kotanides

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Kotanides. A scholar is included among the top collaborators of Helen Kotanides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Kotanides. Helen Kotanides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Beckford-Vera, Denis, et al.. (2023). Abstract 5040: Novel HER3 targeting antibody radioconjugates, 225Ac-HER3 ARC and 177Lu-HER3 ARC, exhibit potent antitumor efficacy in HER3-positive solid tumors. Cancer Research. 83(7_Supplement). 5040–5040. 1 indexed citations
2.
Allen, Kevin J., Jason Li, Madhuri Vusirikala, et al.. (2023). Lintuzumab-Ac225, a CD33-Directed Antibody Radiotherapy, Targets AML in a Mutation Agnostic Manner. Blood. 142(Supplement 1). 5750–5750. 3 indexed citations
3.
Beckford-Vera, Denis, et al.. (2022). Abstract 609: Anti-HER3 radioimmunotherapy enhances the anti-tumor effects of CD47 blockade in solid tumors. Cancer Research. 82(12_Supplement). 609–609. 1 indexed citations
4.
Beckford-Vera, Denis, et al.. (2022). Abstract 3306: Targeting HER3 receptor positive cancers with a novel anti-HER3 antibody radioconjugate (ARC). Cancer Research. 82(12_Supplement). 3306–3306. 1 indexed citations
5.
Lin, Guiting, Huixi Li, Xiaoyu Zhang, et al.. (2014). Novel Therapeutic Approach for Neurogenic Erectile Dysfunction: Effect of Neurotrophic Tyrosine Kinase Receptor Type 1 Monoclonal Antibody. European Urology. 67(4). 716–726. 36 indexed citations
6.
Brennan, Laura, Marie Prewett, Inga Duignan, et al.. (2014). A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth. Cancer Biology & Therapy. 15(9). 1208–1218. 11 indexed citations
7.
8.
Ludwig, Dale L., et al.. (2001). Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene. Gene. 269(1-2). 103–112. 46 indexed citations
9.
10.
Lü, Dan, Helen Kotanides, Xenia Jimenez, et al.. (1999). Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2. Journal of Immunological Methods. 230(1-2). 159–171. 29 indexed citations
11.
Zhu, Zhenping, Dan Lu, Helen Kotanides, et al.. (1999). Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody. Cancer Letters. 136(2). 203–213. 43 indexed citations
12.
Witte, Larry, Daniel J. Hicklin, Zhenping Zhu, et al.. (1998). Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer and Metastasis Reviews. 17(2). 155–161. 262 indexed citations
13.
Zhu, Z, Patricia Rockwell, Dan Lu, et al.. (1998). Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.. PubMed. 58(15). 3209–14. 91 indexed citations
14.
Kotanides, Helen & Nancy C. Reich. (1996). Interleukin-4-induced STAT6 Recognizes and Activates a Target Site in the Promoter of the Interleukin-4 Receptor Gene. Journal of Biological Chemistry. 271(41). 25555–25561. 96 indexed citations
15.
Kotanides, Helen, et al.. (1995). Characterization of the Interleukin-4 Nuclear Activated Factor/STAT and Its Activation Independent of the Insulin Receptor Substrate Proteins. Journal of Biological Chemistry. 270(33). 19481–19486. 37 indexed citations
16.
Kotanides, Helen & Nancy C. Reich. (1993). Requirement of Tyrosine Phosphorylation for Rapid Activation of a DNA Binding Factor by IL-4. Science. 262(5137). 1265–1267. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle B. Crosby Breakdown of academic impact, for papers by Laura Gualandi Breakdown of academic impact, for papers by Susana Constantino Rosa Santos Breakdown of academic impact, for papers by Cheryl J. Aslakson Breakdown of academic impact, for papers by Sina Koch Breakdown of academic impact, for papers by Rosana Meyer Breakdown of academic impact, for papers by Jae Youn Yi Breakdown of academic impact, for papers by Andreas Menrad Breakdown of academic impact, for papers by Lucia Fallavollita Breakdown of academic impact, for papers by Hany Kayed
Rankless by CCL
2026